Immunohistochemical analysis of short-segment Barrett's esophagus

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 12, 2004, Pages 1410-1416

  Ishizuka, Izumi ^a   Andoh, Akira ^a   Koyama, Shigeki ^a   Moritani, Suzuko ^a   Kushima, Ryoji ^a   Hattori, Takanori ^a   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Goblet cell type metaplasia; Long segment Barrett's esophagus; Short segment Barrett's esophagus

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CONCANAVALIN A; MUCIN 2; MUCIN 5AC;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; COLUMNAR EPITHELIUM; DISEASE COURSE; DYSPLASIA; ENDOSCOPE; GOBLET CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METAPLASIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYLORUS; STOMACH EPITHELIUM; STOMACH FUNDUS;

EID: 11144230967     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03519.x     Document Type: Article

References (23)

1. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614-21.
2. Tytgat GNJ, Hameeteman MD. The neoplastic potential of columnar-lined (Barrett's) esophagus. World J. Surg. 1992; 16: 308-12.
3. Skinner DB, Walter BC, Riddel RH et al. Barrett's esophagus; comparison of benign and malignant cases. Ann. Surg. 1983; 198: 554-66.
4. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol. 1994; 25: 982-93.
5. Dent J, Bremner CG, Collen MJ et al. Working party report to the world congress of gastroenterology, Sydney, 1990; Barrett's esophagus. J. Gastroenterol. Hepatol. 1991; 6: 1-22.
6. Weston AP, Krmpotich P, Makdisi WF et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am. J. Gastroenterol. 1996; 91: 981-6.
7. Weston A, Krmpotich P, Cherian R et al. Prospective long term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am. J. Gastroenterol. 1997; 92: 407-13.
8. Sharma P, Morales TG, Bhattachayya A et al. Dysplasia in short segment Barrett's esophagus: a prospective 3-year follow-up. Am. J. Gastroenterol. 1997; 92: 2012-16.
9. Paull A, Trier JS, Dalton D et al. The histologic spectrum of Barrett's esophagus. N. Engl. J. Med. 1976; 295: 476-80.
10. Watanabe H, Komukai S, Ochiai A et al. Histopathology Barrett's epithelium. Stomach Intestine (Jpn) 1999; 34: 123-32.
11. Thompson JJ, Zinsser KR, Enterline HT. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum. Pathol. 1983; 14: 42-61.
12. Matsukita S, Nomoto M, Kitajima S et al. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Histopathology 2003; 42: 26-36.
13. Ota H, Nakayama J, Momose M et al. New monoclonal antibodies against gastric gland mucous cell-type mucins: a comparative immunohistochemical study. Histochem. Cell Biol 1998; 110: 113-19.
14. Nishiyama Y, Koyama S, Andoh A et al. Immunohistochemical analysis of cell cycle-regulating-protein (p21, p27, and Ki-67) expression in gastroesophageal reflux disease. J. Gastroenterol. 2002; 37: 905-11.
15. Ormsby AH, Goldblum JR, Rice TW et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum. Pathol. 1999; 30: 288-94.
16. Ormsby AH, Vaezi MF, Richter JE et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 2000; 119: 683-90.
17. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983; 31: 13-20.
18. Endo T, Awakawa T, Takahashi H et al. Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest. Endosc. 2002; 55: 641-7.
19. Gulizia JM, Wang H, Antonioli D et al. Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short-segment Barrett's esophagus): a case control study. Hum. Pathol. 1999; 30: 412-18.
20. Guelrud M, Herrera I, Essenfeld H et al. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest. Endosc. 2001; S3: 559-65.
21. Canto MI, Setrakian S, Petras RE et al. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest. Endosc. 1996; 44: 1-7.
22. Canto MI, Setrakian S, Willis J et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest. Endosc. 2000; 51: 560-8.
23. Tabuchi M, Sueoka N, Fujimori T. Videoendoscopy with vital double dye staining (crystal violet and methylene blue) for detection of a minute ficus of early stage adenocarcinoma in Barrett's esophagus: a case report. Gastrointest. Endosc. 2001; 54: 385-8.